Mass General Brigham Cancer Institute at Massachusetts General Hospital — Boston, Massachusetts

Mass General Brigham Cancer Institute at Massachusetts General Hospital is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Mass General Brigham Cancer Institute at Massachusetts General Hospital has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: KRAS-mutant Non-small Cell Lung Cancer (NSCLC), KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC), KRAS-mutant Colorectal Cancer (CRC).

Sponsors: Kestrel Therapeutics, Inc., Zeba Ahmad, Ph.D..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

• Massachusetts General Hospital Translational and Clinical Research Center
• Boston VA CSP Coordinating Center
• Boston Children's Hospital / Dana Farber Cancer Institute / Massachusetts General Hospital
• Massachusetts General Hospital Site Number : 002
• Laboratories of Cognitive Neuroscience, Boston Children's Hospital
• The Brigham and Women's Hospital Department of Anesthesiology
• Tuft University Hospital
• Boston Children's Hospital /ID# 162863
• Dana Farber Cancer Institute/Children's Hospital of Boston
• Brigham and Women's Hospital
• Brigham & Woman's Hospital/Boston
• Caritus St. Elizabeth's Hospital

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mass General Brigham Cancer Institute at Massachusetts General Hospital?

Mass General Brigham Cancer Institute at Massachusetts General Hospital has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mass General Brigham Cancer Institute at Massachusetts General Hospital conducted?

Mass General Brigham Cancer Institute at Massachusetts General Hospital has 2 clinical trials on record, with 2 currently active. Their work covers KRAS-mutant Non-small Cell Lung Cancer (NSCLC), KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC), KRAS-mutant Colorectal Cancer (CRC).

Is Mass General Brigham Cancer Institute at Massachusetts General Hospital accredited by Crixeo Clinical Trials?

Mass General Brigham Cancer Institute at Massachusetts General Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mass General Brigham Cancer Institute at Massachusetts General Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.